News

Anthem Biosciences Listing: Anthem Biosciences Ltd., which is a fully integrated operations encompassing drug discovery, development, and manufacturing processes, listed on BSE and NSE today (Monday, July 21, 2025) with a 27 per cent premium on each.

It listed on BSE at Rs 723.10, at a 26.86 per cent premium.

The stock listed on NSE at Rs 723.05, a premium of 26.85 per cent. 

The offer for sale IPO, which opened on July 14 and closed on July 16, had an issue price of Rs 570 per share.

Zee Business managing editor, Anil Singhvi, was also expecting a strong listing for the company at an above-Rs 700 price.

The market guru said that the company could list in the range of Rs 715-Rs 730.

The market wizard advised applying for good listing gains and long-term with 2-3 years of perspective.

To short-term investors, he advised holding the stock with a stop loss of Rs 675.

Singhvi said that long-term investors must hold the Anthem Biosciences stock in their portfolio.

The lot size of the share was 26, while the minimum investment for retail investors was Rs 14,820. 

The bookbuilding IPO's tentative allotment of shares was done on July 17, while initiation of funds took place on July 18.

The credit of shares to demat accounts was also done on the same day.

Qualified institutional buyers subscribed the IPO by 192.80 times, while non-institutional bidders subscribed by 44.70 times.

Retail investors did it by 5.98 times and employees by 6.99 times.

In total, it was subscribed by 67.42 times.

Get Latest Business News, Stock Market Updates and Videos; Check your tax outgo through Income Tax Calculator and save money through our Personal Finance coverage. Check Business Breaking News Live on Zee Business Twitter and Facebook. Subscribe on YouTube.

LATEST NEWSBy accepting cookies, you agree to the storing of cookies on your device to enhance site navigation, analyze site usage, and assist in our marketing efforts.